Sustained increases in ADHD medication use after the COVID-19 pandemic: A nationwide register-based study

Aims

To examine population-level trends in attention-deficit/hyperactivity disorder (ADHD) medication use in Norway before, during, and after the COVID-19 pandemic, and to identify age and sex groups with particularly pronounced changes, using interrupted time series analysis to test for a shift in trend from 2020.